New immune cell therapy tested for leukemia that Won't quit
Disease control
Terminated
This study tested an experimental cell therapy called TCB008 for adults with acute myeloid leukemia (AML) or related conditions where the cancer has returned or not responded to standard treatments. The therapy involves infusing specially grown immune cells from healthy donors to…
Phase: PHASE2 • Sponsor: TC Biopharm • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC